Trials / Not Yet Recruiting
Not Yet RecruitingNCT06891001
The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance, Biomechanics, and Pain Intensity
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 36 (estimated)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
We hypothesize that the addition of a unilateral neutral shoe insert combined with standard physical therapy (PT+SI) will have greater improvements in pain and function at 12 weeks and 6 months compared to physical therapy with sham inserts (PT+Sham) and physical therapy (PT) alone. In addition, we hypothesize that the addition of a neutral shoe insert in the involved limb will immediately improve biomechanics and pain with the single-leg stance test.
Conditions
- Gluteus Medius Muscle Strength
- Lateral Hip Pain
- Greater Trochanter Pain Syndrome, Gluteus Medius Tendinopathy, Gluteus Minimus Tendinopathy
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Unilateral neutral shoe insert | In the treatment group, subjects will undergo the addition of a neutral shoe insert to the involved lower extremity according to manufacturer guidelines at the initial visit. These subjects will also undergo a once-weekly 12-week course of physical therapy according to the established standardized protocol. |
| DEVICE | Bilateral Shoe Insert | For subjects placed in the sham group, subjects will undergo the addition of a neutral shoe insert to both lower extremities according to manufacturer guidelines at the initial visit. These subjects will also undergo a once-weekly 12-week course of physical therapy according to the established standardized protocol with guidelines . |
| OTHER | Physical Therapy | For subjects placed in the control group, subjects will undergo a once-weekly 12-week course of physical therapy according to the established standardized protocol. |
Timeline
- Start date
- 2027-01-01
- Primary completion
- 2028-01-01
- Completion
- 2029-01-01
- First posted
- 2025-03-24
- Last updated
- 2026-01-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06891001. Inclusion in this directory is not an endorsement.